Patent US5154914A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5154914A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods of diagnostic image analysis using lipophilic contrast agents

Assignee: RESEARCH Corp TECHNOLOGIES Inc A NOT-FOR-PROFIT NON-STOCK CORP OF
•
Filing: 1990-03-12
•
Granted: 1992-10-13
•
Expires: 2010-03-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to contrast enhancing agents, conjugates thereof, pharmaceutical compositions thereof, and methods for diagnostic analysis, particularly NMR image analysis using these agents. The contrast enhancing agents are chelates of paramagnetic, ferromagnetic or diamagnetic metal ion(s) complexed with new lipophilic complexing acids related to polyaminopolycarboxylic acids.

Inventors

  • 👤 Gabriel A. Elgavish
  • 👤 Sung K. Kim

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:10
CPC Classifications
G; G01; G01R; G01R33/00; G01R33/20; G01R33/44; G01R33/48; G01R33/54; G01R33/56; G01R33/5601; A; A61; A61K; A61K49/00; A61K49/0002; A61K49/04; A61K49/06; A61K49/08; A61K49/085; A61K49/10; A61K49/101; A61K49/103; A61K49/18; A61K49/1806; A61K49/1812; Y; Y10; Y10S; Y10S436/00; Y10S436/806; Y10T; Y10T436/00; Y10T436/24

Claims Analysis

Total Claims: 35
Claim 1
Independent Claim 200 words
A method for magnetic resonance imaging comprising administering to a host a contrast enhancing amount of a contrast enhancing agent which comprises a complexing acid or a salt thereof and at least one metal ion of an element with an atomic number 21 to 29, 42 to 44 or 57 to 83, wherein said acid has the formula ##STR17## wherein a is 0 to 5; b is 1 to 5; each of a and b can be the same or different; each R is hydrogen, lower alkyl, hydroxy, halo, lower alkyoxy, aryl, or lower aralkyl; at least one of R 1 , R 2 , R 3 , R 4 or X has the formula ##STR18## wherein R 5 is a saturated or unsaturated hydrocarbon chain having 6 to 30 carbon atoms; and the others of R 1 , R 2 , R 3 , R 4 , or X are hydrogen, hydroxyl, --COOR 6 , --CONR 7 R 8 or a chelating moiety wherein R 6 , R 7 , and R 8 are the same or different and represent hydrogen, lower alkyl, lower alkoxy, lower carboxyalkylene, or a chelating moiety; and subjecting said host to magnetic resonance imaging.
Claim 2
Independent Claim 200 words
A method for magnetic resonance imaging comprising administering to a host a contrast enhancing amount of a contrast enhancing agent which comprises a complexing acid or a salt thereof and at least one metal ion of an element with an atomic number 21 to 29, 42 to 44 or 57 to 83, wherein said acid has the formula ##STR17## wherein a is 0 to 5; b is 1 to 5; each of a and b can be the same or different; each R is hydrogen, lower alkyl, hydroxy, halo, lower alkyoxy, aryl, or lower aralkyl; at least one of R 1 , R 2 , R 3 , R 4 or X has the formula ##STR18## wherein R 5 is a saturated or unsaturated hydrocarbon chain having 6 to 30 carbon atoms; and the others of R 1 , R 2 , R 3 , R 4 , or X are hydrogen, hydroxyl, --COOR 6 , --CONR 7 R 8 or a chelating moiety wherein R 6 , R 7 , and R 8 are the same or different and represent hydrogen, lower alkyl, lower alkoxy, lower carboxyalkylene, or a chelating moiety; and subjecting said host to magnetic resonance imaging.
Claim 3
Dependent Claim 11 words
The method of claim 1 wherein said host is a mammal.
Claim 4
Dependent Claim 18 words
The method of claim 1 wherein said megnetic resonance imaging is directed to a tissue of said host.
Claim 5
Dependent Claim 11 words
The method of claim 3 wherein said tissue is cardiac tissue.
Claim 6
Dependent Claim 23 words
The method of claim 1, wherein R 5 is a hydrocarbon chain substituted with a lower alkyl, hydroxyl, lower alkoxy or halogen moiety.
Claim 7
Dependent Claim 19 words
The method of claim 1, wherein R 5 is a saturated alkyl chain having 6 to 30 carbon atoms.
Claim 8
Dependent Claim 15 words
The method of claim 6, wherein said alkyl chain has 8 to 24 carbon atoms.
Claim 9
Dependent Claim 7 words
The method of claim 1, wherein ##STR19##
Claim 10
Dependent Claim 28 words
The method of claim 8, wherein R is hydrogen, R 2 , R 3 , R 4 and X are COOR 6 , and R 6 is hydrogen.
Claim 11
Dependent Claim 7 words
The method of claim 1, wherein ##STR20##
Claim 12
Dependent Claim 29 words
The method of claim 10 wherein R is hydrogen, R 1 , R 2 , R 3 and R 4 are COOR 6 , and R 6 is hydrogen.
Claim 13
Dependent Claim 33 words
The method of claim 8 wherein R is hydrogen, R 2 and R 4 are --CONR 7 R 8 , R 3 is hydroxyl, and R 7 and R 8 are lower carboxyalkylene.
Claim 14
Dependent Claim 9 words
The method of claim 12, wherein a is 0.
Claim 15
Dependent Claim 7 words
The method of claim 1 wherein ##STR21##
Claim 16
Dependent Claim 23 words
The method of claim 14 wherein R is hydrogen, R 2 and R 4 are COOR 6 , and R 6 is hydrogen.
Claim 17
Dependent Claim 9 words
The method of claim 15 wherein a is 0.
Claim 18
Dependent Claim 28 words
The method of claim 14 wherein R is hydrogen, R 2 and R 4 are --CONR 7 R 8 and R 7 and R 8 are lower carboxyalkylene.
Claim 19
Dependent Claim 9 words
The method of claim 17 wherein a is 0.
Claim 20
Dependent Claim 12 words
The method of claim 1 wherein said complexing acid is N-(2-myristoyloxyethyl)-N'-(2-hydroxyethyl)-N,N'-bis[N",N"-bis(carboxymethyl)acetamido]1,2-ethanediamine. ine.
Claim 21
Dependent Claim 11 words
The method of claim 1 wherein said complexing acid is N,N'-bis(2-myristoyloxyethyl)N,N'-bis[N",N"-bis(carboxymethyl)acetamido]-1,2-ethanediamine.
Claim 22
Dependent Claim 12 words
The method of claim 1 wherein said complexing acid is N-(3-myristoyloxypropyl)diethylenetriamineN,N',N",N"-tetraacetic acid.
Claim 23
Dependent Claim 11 words
The method of claim 1 wherein said complexing acid is N-(3-myristoyloxypropyl)-N,N-bis[2-[N',N'-bis(carboxymethyl)nitrilo]ethyl]amine.
Claim 24
Dependent Claim 26 words
The method of claim 1 wherein said contrast enhancing amount is about 0.001 mmole to about 5 mmole of said agent per kilogram of said host.
Claim 25
Independent Claim 150 words
A method for magnetic resonance imaging administering to a host a contrast enhancing amount of a contrast enhancing agent which comprises a complexing acid or a salt thereof and at least one metal ion of an element with an atomic number 21 to 29, 42 to 44 or 57 to 83, wherein said acid has the formula: ##STR22## wherein at least one of R 1 , R 2 , R 3 or R 4 has the formula ##STR23## wherein R 5 is a saturated or unsaturated hydrocarbon chain having 6 to 30 carbon atoms; and the others of R 1 , R 2 , R 3 or R 4 are hydrogen, hydroxyl, --COOR 6 , --CONR 7 R 8 or a chelating moiety, wherein R 6 , R 7 or R 8 are the same or different and are hydrogen, lower alkyl, lower alkoxy, lower carboxyalkylene, or a chelating moiety.
Claim 26
Independent Claim 150 words
A method for magnetic resonance imaging administering to a host a contrast enhancing amount of a contrast enhancing agent which comprises a complexing acid or a salt thereof and at least one metal ion of an element with an atomic number 21 to 29, 42 to 44 or 57 to 83, wherein said acid has the formula: ##STR22## wherein at least one of R 1 , R 2 , R 3 or R 4 has the formula ##STR23## wherein R 5 is a saturated or unsaturated hydrocarbon chain having 6 to 30 carbon atoms; and the others of R 1 , R 2 , R 3 or R 4 are hydrogen, hydroxyl, --COOR 6 , --CONR 7 R 8 or a chelating moiety, wherein R 6 , R 7 or R 8 are the same or different and are hydrogen, lower alkyl, lower alkoxy, lower carboxyalkylene, or a chelating moiety.
Claim 27
Dependent Claim 23 words
The method of claim 24 wherein R 5 is a hydrocarbon chain substituted with a lower alkyl, hydroxyl, lower alkoxy or halogen moiety.
Claim 28
Dependent Claim 19 words
The method of claim 24 wherein R 5 is a saturated alkyl chain having 6 to 30 carbon atoms.
Claim 29
Dependent Claim 15 words
The method of claim 25 wherein said alkyl chain has 8 to 24 carbon atoms.
Claim 30
Dependent Claim 10 words
The method of claim 24 wherein R 1 is ##STR24##
Claim 31
Dependent Claim 26 words
The method of claim 28, wherein R is hydrogen, R 2 , R 3 and R 4 are COOR 6 , and R 6 is hydrogen.
Claim 32
Dependent Claim 33 words
The method of claim 28 wherein R is hydrogen, R 2 and R 4 are --CONR 7 R 8 , R 3 is hydroxyl, and R 7 and R 8 are lower carboxyalkylene.
Claim 33
Dependent Claim 13 words
The method of claim 24 wherein R 1 and R 3 are ##STR25##
Claim 34
Dependent Claim 23 words
The method of claim 31 wherein R is hydrogen, R 2 and R 4 are COOR 6 , and R 6 is hydrogen.
Claim 35
Dependent Claim 28 words
The method of claim 31 wherein R is hydrogen, R 2 and R 4 are --CONR 7 R 8 and R 7 and R 8 are lower carboxyalkylene.

References Cited (Backward Citations)

US3429915A Cited
DE2341045A1 Cited
US4647447A Cited
US5021236A Cited
US4804529A Cited
US4687658A Cited
US4687659A Cited
US4826673A Cited
EP0250358A2 Cited
JPH01120384A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-10-13 1996-04-13 1996-10-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-10-13 2000-04-13 2000-10-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-10-13 2004-04-13 2004-10-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag